Related Experiment Videos
Miliary coccidioidomycosis in the immunocompetent.
1Kern Medical Center, Department of Internal Medicine, Bakersfield, CA, USA.
Chest
|February 12, 2000
Summary
Miliary coccidioidomycosis, typically seen in immunocompromised individuals, can affect immunocompetent patients. This study details eight such cases, highlighting diagnostic factors and a better prognosis than previously reported for this Coccidioides immitis infection.
Area of Science:
- Infectious Diseases
- Pulmonology
- Mycology
Background:
- Miliary coccidioidomycosis, a disseminated form of Coccidioides immitis infection, typically affects immunocompromised individuals.
- Previous literature suggests a poor prognosis, often leading to respiratory failure in immunocompromised patients.
- This study focuses on the largest series of immunocompetent patients diagnosed with miliary coccidioidomycosis.
Purpose of the Study:
- To describe the clinical characteristics of miliary coccidioidomycosis in immunocompetent patients.
- To outline key diagnostic considerations for this condition.
- To report treatment outcomes and mortality rates in this specific patient group.
Main Methods:
- Retrospective analysis of eight immunocompetent patients diagnosed with miliary coccidioidomycosis between 1990 and 1997.
- Inclusion criteria: diagnosis of miliary coccidioidomycosis, absence of HIV, and confirmation by C. immitis identification.
- Miliary pattern defined radiographically as diffuse 2- to 10-mm lesions in both lung fields.
Main Results:
- Eight immunocompetent patients (23-65 years) were identified, representing 1% of coccidioidomycosis admissions.
- Patients presented with either acute (<1 week) or chronic (5-12 weeks) symptoms.
- Five patients developed acute respiratory distress syndrome (ARDS), and four had meningeal and/or skin involvement; three patients died, all with chronic disease.
Conclusions:
- Miliary coccidioidomycosis in immunocompetent patients can present as acute respiratory illness or advanced chronic disease.
- Outcomes in this series were better than previously reported, with lower mortality.
- Prompt recognition is crucial, aided by travel history, ethnicity, immunologic status, multi-organ involvement, and unexplained hypoxemia.